| For: | Freire de Melo F, Marques HS, Rocha Pinheiro SL, Lemos FFB, Silva Luz M, Nayara Teixeira K, Souza CL, Oliveira MV. Influence of Helicobacter pylori oncoprotein CagA in gastric cancer: A critical-reflective analysis. World J Clin Oncol 2022; 13(11): 866-879 [PMID: 36483973 DOI: 10.5306/wjco.v13.i11.866] |
|---|---|
| URL: | https://www.wjgnet.com/2222-0682/full/v13/i11/866.htm |
| Number | Citing Articles |
| 1 |
Burcu Gemici. Mucosal Barriers and Host-Microbiota Interplay. 2026; doi: 10.1016/B978-0-443-40306-4.00001-6
|
| 2 |
Yan Wang, Dajun Chen, Shuai Qian, Fengping Wang, Huibin Weng. CagA promotes gastric cancer stemness and metastasis via DNMT1-mediated epigenetic silencing of BEX1. Cancer Gene Therapy 2026; doi: 10.1038/s41417-026-01057-0
|
| 3 |
Helge Waldum, Reidar Fossmark. Inflammation and Digestive Cancer. International Journal of Molecular Sciences 2023; 24(17) doi: 10.3390/ijms241713503
|
| 4 |
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki. Helicobacter pylori and gastric cancer: a critical approach to who really needs eradication. Exploration of Digestive Diseases 2024; doi: 10.37349/edd.2024.00043
|
| 5 |
Athena Myrou. Molecular Mechanisms and Treatment Strategies for Helicobacter pylori-Induced Gastric Carcinogenesis and Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma. Cureus 2024; doi: 10.7759/cureus.60326
|
| 6 |
Marta Majchrzak, Samuel Paterson, Pilar Gómez-Cortés, Jose Manuel Silvan, Adolfo J. Martinez-Rodriguez, Blanca Hernández-Ledesma. Tetraselmis chuii as Source of Bioactive Compounds Against Helicobacter pylori: An Integrated Proteomic and Bioactivity Approach. Molecules 2025; 30(24) doi: 10.3390/molecules30244669
|
| 7 |
Ragheb Alsheikh Zein, Rawan R. Kawaf, Wafaa S. Ramadan, Rose Ghemrawi, Rania Harati, Raafat El-Awady, Ghalia Khoder. Structural and molecular insights into Helicobacter pylori CagA-SHP2 complex: From pathogenic signaling to targeted therapeutic opportunities in gastric cancer. Microbiological Research 2026; 312 doi: 10.1016/j.micres.2026.128632
|
| 8 |
Stella G. Hoft, Michelle Brennan, Javier A. Carrero, Nicholas M. Jackson, Challen A. Pretorius, Tarin M. Bigley, José B. Sáenz, Richard J. DiPaolo. Unveiling Cancer-Related Metaplastic Cells in Both Helicobacter pylori Infection and Autoimmune Gastritis. Gastroenterology 2025; 168(1) doi: 10.1053/j.gastro.2024.08.032
|
| 9 |
Derick Okwan-Duodu, Arun R. Pandiri, David J. Adams. Not All Carcinogens Are Directly Mutagenic: A Holistic View of the Environmental Exposure–Cancer Connection.
Annual Review of Cancer Biology
2025; 9(1) doi: 10.1146/annurev-cancerbio-060424-052905
|
| 10 |
Suhua Li, Xuehong Wang. Helicobacter pylori CagA protein confers aggressive phenotypes to gastric cancer cells through the HIF-1α-mediated metabolic reprogramming. Molecular & Cellular Toxicology 2026; 22(2) doi: 10.1007/s13273-025-00577-4
|
| 11 |
Xiaofei Ji, Zekun Sun, Hao Wu, Jianhui Zhang, Shuzhen Liu, Xinying Cao, Bin Wang, Feifan Wang, Ying Zhang, Boqing Li, Jiankai Feng, Huilin Zhao. More powerful dysregulation of Helicobacter pylori East Asian-type CagA on intracellular signalings. BMC Microbiology 2024; 24(1) doi: 10.1186/s12866-024-03619-4
|
| 12 |
Adekunle Rowaiye, Gordon C. Ibeanu, Doofan Bur, Sandra Nnadi, Odinaka E. Mgbeke, Ugonna Morikwe. Gut microbiota alteration - Cancer relationships and synbiotic roles in cancer therapies. The Microbe 2024; 4 doi: 10.1016/j.microb.2024.100096
|
| 13 |
Mohamed Halawa, Precious M. Newman, Tope Aderibigbe, Valerie J. Carabetta. Conjugated therapeutic proteins as a treatment for bacteria which trigger cancer development. iScience 2024; 27(10) doi: 10.1016/j.isci.2024.111029
|
| 14 |
Juan Marcos Caram Costa, Carlos Eduardo Oliveira Aguiar, Marina Maria Gomes Leite Oliveira, Victoria Cenci Dietrich, Pedro Henrique Melo Lima, João Pedro Camargo Freire, Fabian Fellipe Bueno Lemos, Dulciene Maria de Magalhães Queiroz, Fabrício Freire de Melo. Update on the pathogenesis and clinical management of <i>Helicobacter pylori</i> gastric infection and associated diseases. World Journal of Gastrointestinal Pathophysiology 2025; 16(4): 111432 doi: 10.4291/wjgp.v16.i4.111432
|
| 15 |
Claire Morin, Vijay Tailor Verma, Tarun Arya, Bastien Casu, Eric Jolicoeur, Réjean Ruel, Anne Marinier, Jurgen Sygusch, Christian Baron. Structure-based design of small molecule inhibitors of the cagT4SS ATPase Cagα of Helicobacter pylori. Biochemistry and Cell Biology 2024; 102(3) doi: 10.1139/bcb-2023-0331
|
| 16 |
Katarzyna Grychowska, Karolina Klesiewicz, Joanna Pęgiel, Agata Kuziak, Iwona Skiba-Kurek, Vittorio Canale, Gracjana Krzysiek-Mączka, Agata Ptak-Belowska, Kamil Piska, Paulina Koczurkiewicz-Adamczyk, Paweł Krzyżek, Tomasz Brzozowski, Paweł Zajdel, Elżbieta Karczewska. New Quipazine Derivatives Active Against Drug-Resistant Oncogenic Helicobacter pylori Strains with Biofilm. International Journal of Molecular Sciences 2025; 26(13) doi: 10.3390/ijms26135997
|
| 17 |
Paria Ghadersoltani, Shahrzad Shoraka, Alireza Sadjadi, Parastoo Saniee. Long-term assessment of Helicobacter pylori cagA EPIYA motif changes and pathology outcomes in gastric biopsies of dyspeptic patients: 10-year follow-up. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03516-0
|